SCHEMBL9485728

SCHEMBL9485728

COCCn1cnc(CN2CCc3c(c4cccc(F)c4n3C)C2=O)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.44
HTR2A P28223 2/20 0.44
HTR2C P28335 2/20 0.44
HTR2B P41595 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADRA2C P18825 1/20 0.44
ADRA1A P35348 1/20 0.44
HTR3A P46098 1/20 0.44
CASP6 P55212 1/20 0.44
SCN9A Q15858 1/20 0.32
HRH3 Q9Y5N1 2/20 0.32
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
HTR5A P47898 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
PDE4A P27815 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA2B P29275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7285963 0.92 KCNH2 (0.45) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL7295411 0.86 HTR2A (0.49) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL9485723 0.83 HTR2A (0.44) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL7286207 0.81 KCNH2 (0.41) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL9485681 0.80 KCNH2 (0.44) KCNH2HTR2AHTR2CHTR2BCYP1A2
Lurosetron SCHEMBL30949356 0.78 KCNH2 (0.72) KCNH2HTR2AHTR2CHTR2BCYP1A2
Lurosetron SCHEMBL788289 0.78 KCNH2 (0.72) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL7284034 0.78 KCNH2 (0.42) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL1484 0.77 KCNH2 (0.62) KCNH2HTR2AHTR2CHTR2BCYP1A2
Lurosetron SCHEMBL7336906 0.77 KCNH2 (0.71) KCNH2HTR2AHTR2CHTR2BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed